A COX-2 inhibitor, celecoxib (CXB), alone or combined with TMZ, was used on T98G (TMZ-resistant) and U87MG (TMZ-partially resistant) [28] and GBM primary cultures. This evidence concerns the gene PTGS2 and glioblastoma.